In the speedily evolving industry of most cancers therapeutics, knowledge the intricate mechanisms of Antibody-Drug Conjugates (ADCs) is essential for acquiring efficient treatment options. One of the more promising strategies is the use of in vitro bystander outcome assays, which Perform a pivotal function in maximizing therapeutic efficacy. These